Ledger.Open graph →

SEC Form D · filed December 30, 2022

Cardurion Pharmaceuticals, Inc

Offering

$17.5M

Sold

$17.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BURLINGTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Kenneth Novack · Burlington, MADirector Michael Mendelsohn · Burlington, MAExec · Director Keith Gottesdiener · Burlington, MADirector Nicholas Downing · Burlington, MADirector Adam Koppel · Burlington, MADirector Jeb Keiper · Burlington, MADirector Peter Lawrence · Burlington, MAExec · Director Austin Watkins · Edmonds, WADirector Chris Bakker · Calgary, Alberta, CanadaExec · Director Sandeep Kini · Edmonds, WAExec · Director Ryan Agresta · Edmonds, WADirector Michael Leo · Calgary, Alberta, CanadaDirector Greg Bronson · Calgary, Alberta, CanadaDirector Brad Paterson · Calgary, Alberta, CanadaDirector Amy Schulman · Waltham, MADirector Melissa Lee · Ottawa, OHDirector Nemanja Kostic · San Francisco, CADirector Christopher Golda · San Francisco, CAExec · Director Mark H. Longenecker · Chicago, ILDirector Jonathan Berent · Mountain View, CADirector John Kuelper · Mountain View, CAExec · Director Julie O'Hara · Grand Cayman, Cayman IslandsDirector Amy Schulman · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗